33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell LyLisocabtagene maraleucel in relapsed/refractory large B-cell lymphoma: Real world analysis from the Cell Therapy Consortiummphoma: Real World Analysis from the Cell Therapy Consortium
    Meeting Abstract

    Riedell, P. A.; Grady, C.; Nastoupil, L. J.; Luna, A.; Ahmed, N.; Maziarz, R. T.; Hu, M.; Brower, J.; Hwang, W. T.; Schuster, S. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • What is the optimal treatment modality in molecularly defined secondary AML? A multicenter cohort study
    Meeting Abstract

    Shimony, S.; Bewersdorf, J. P.; Shallis, R. M.; Liu, Y. W.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A. D.; Stein, E. M.; Marcucci, G.; Chen, E. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis and thrombocytopenia
    Meeting Abstract

    Michael, A., Jr.; Turizo, M. J. F.; Dodge, L.; Hsu, C.; Barnum, K.; Zwicker, J. I.; Patell, R.
    Blood (2023)

    Fulltext@MSK | Save
  • Development of a fully immunocompetent adoptive transfer in vivo model of Npm1(cA); Idh2(R140Q); Flt3(ITD) AML
    Meeting Abstract

    Sharpe, C.; Johnson, M.; Fobare, S.; Elgamal, O. A.; Harrington, B. K.; Mustonen, A.; Bryant, K.; Cheney, C.; Lerma, J. R.; Truxall, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world outcomes of brexucabtagene autoleucel ( brexu-cel) for relapsed or refractory (R/R) adult B-cell acute lymphoblastic leukemia (B-cell ALL): Evidence from the CIBMTR registry
    Meeting Abstract

    Bezerra, E.; Itani, T.; Wudhikarn, K.; Perales, M. A.; Yang, Y.; Gergis, U.; Aribi, A.; Hill, L. C.; Jain, N.; Leonard, J. T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Preliminary results of a phase 2a clinical trial to evaluate safety, tolerability and antiviral activity of intravenous brincidofovir (BCV IV) in immunocompromised patients with adenovirus infection
    Meeting Abstract

    Grimley, M.; Maron, G.; Gomez, C. A.; Prasad, V. K.; Dara, J.; Papanicolaou, G. A.; Fukushima, K.; Wynn, R. F.; Boeckh, M.
    Blood (2023)

    Fulltext@MSK | Save
  • Low dose total body irradiation improves CD19 CAR-T expansion, persistence, and trafficking, leading to enhanced efficacy in large B-cell lymphoma
    Meeting Abstract

    Alhomoud, M.; Foley, M.; Sugita, M.; Yamazaki, T.; Martinez, L.; Yamshon, S.; Gomez-Arteaga, A.; Pagnini, P.; Shore, T. B.; Boyer, O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Efficacy of subcutaneous epcoritamab vs tisa-cel in R/R LBCL CAR T-naive and CAR T-eligible patients: An indirect comparison
    Meeting Abstract

    Salles, G.; Fox, C. P.; Wang, A.; Sail, K.; Alshreef, A.; Moran, M.; Mutebi, A.; Blaedel, J.; Chirikov, V.; Wang, W. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genomic and transcriptomic landscape of hyper-APOBEC multiple myeloma
    Meeting Abstract

    Papadimitriou, M.; Tauro, M.; Ziccheddu, B.; Poos, A. M.; Alaoui, A. Y.; Meads, M. B.; Maclachlan, K. H.; Usmani, S. Z.; Raab, M. S.; Morgan, G. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Ubiquitin ligase SCF-FBXO11 controls a network of RNA-binding proteins and splicing in MDS
    Meeting Abstract

    Niederkorn, M.; Bezavada, L.; Cotton, A.; Palmer, L.; Hall, T.; Schieber, M.; Xu, P.; Weiss, M.; Rampal, R. K.; Crispino, J. D.
    Blood (2023)

    Fulltext@MSK | Save